ARK Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-19,362
| Closed | -$1.91M | – | 203 |
|
|
2018
Q2 | $1.91M | Buy |
19,362
+8,250
| +74% | +$813K | 0.07% | 92 |
|
|
2018
Q1 | $1.32M | Buy |
11,112
+9,014
| +430% | +$1.07M | 0.07% | 97 |
|
|
2017
Q4 | $267K | Sell |
2,098
-6,976
| -77% | -$888K | 0.02% | 134 |
|
|
2017
Q3 | $1.07M | Buy |
9,074
+3,798
| +72% | +$446K | 0.13% | 84 |
|
|
2017
Q2 | $421K | Sell |
5,276
-948
| -15% | -$75.6K | 0.08% | 86 |
|
|
2017
Q1 | $319K | Sell |
6,224
-117,506
| -95% | -$6.02M | 0.09% | 73 |
|
|
2016
Q4 | $4.63M | Buy |
+123,730
| New | +$4.63M | 1.69% | 21 |
|